Breaking News Instant updates and real-time market news.

SRPT

Sarepta

$143.85

38.37 (36.38%)

13:35
06/19/18
06/19
13:35
06/19/18
13:35

Sarepta price target raised to $205 from $87 at JPMorgan

JPMorgan analyst Anupam Rama said he is adding Sarepta's micro-dystrophin program to his model following the company's R&D day, reiterating his earlier call that the update "vastly exceeded" expectations. He estimates peak sales of $4B-$5B for the micro-dystrophin program, adding that the breadth of the pipeline highlighted at the R&D day leads him to believe Sarepta has the potential to enter the ranks of the "emerging large-caps" in the next 12-24 months. Rama raised his price target on Sarepta to $205 from $87 and keeps an Overweight rating on the shares.

  • 20

    Jun

SRPT Sarepta
$143.85

38.37 (36.38%)

06/15/18
BTIG
06/15/18
INITIATION
Target $120
BTIG
Buy
Sarepta initiated with a Buy at BTIG
BTIG analyst Timothy Chiang started Sarepta Therapeutics with a Buy rating and $120 price target. The company is the leader in the Duchenne muscular dystrophy space with its Exondys 51 estimated to generate sales of $300M in 2018, and its "extensive pipeline" of RNA-splicing product candidates, Chiang tells investors in a research note. While the stock is up 78% year-to-date, there is the potential for further upside as investors get additional visibility on Sarepta's gene therapy and phosphorodiamidate morpholino oligomer programs, the analyst contends.
06/15/18
JPMS
06/15/18
NO CHANGE
JPMS
Overweight
JPMorgan sees favorable setup for Sarepta into Tuesday's event
JPMorgan analyst Anupam Rama sees a favorable setup for shares of Sarepta Therapeutics(SRPT) into the company's R&D day on Tuesday, June 19. His scenario analysis points to a "very favorable" reward/risk profile of 20%-50% upside versus 10%-25% downside. If the gene therapy data meets or beats expectations, Sarepta will clearly be in the pole position in the micro-dystrophin space, Rama tells investors in a research note. The analyst adds that if the Sarepta micro-dystrophin data are viewed positively next week, a clear bar will have been set that Solid Biosciences (SLDB) will need to meet or beat. Rama continues to see risk to Solid shares ahead of next week's readout from Sarepta. He has an Overweight rating on Sarepta with an $87 price target and Underweight rating on Solid Biosciences with a $10 price target.
06/15/18
06/15/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. PetMed Express (PETS) initiated with a Neutral at CL King. 2. Cloudera (CLDR) initiated with a Reduce at Nomura Instinet. 3. Sarepta (SRPT) initiated with a Buy at BTIG. 4. Delphi Technologies (DLPH) initiated with a Perform at Oppenheimer. 5. Enerplus (ERF) initiated with a Buy at SunTrust. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
06/19/18
JPMS
06/19/18
NO CHANGE
JPMS
Sarepta data beat 'grand slam scenario,' says JPMorgan
JPMorgan analyst Anupam Rama says the micro-dystrophin data reported this morning by Sarepta Therapeutics beat his "grand slam scenario." The stock in morning trading is up 59% to $166.99.

TODAY'S FREE FLY STORIES

KBH

KB Home

$20.80

-0.135 (-0.64%)

07:39
11/15/18
11/15
07:39
11/15/18
07:39
Recommendations
KB Home analyst commentary  »

KB Home price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PANW

Palo Alto Networks

$176.83

-0.11 (-0.06%)

07:39
11/15/18
11/15
07:39
11/15/18
07:39
Recommendations
Palo Alto Networks analyst commentary  »

Palo Alto Networks…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 19

    Nov

  • 29

    Nov

  • 10

    Dec

  • 09

    Jan

  • 10

    Jan

JCP

J.C. Penney

$1.23

-0.05 (-3.91%)

07:39
11/15/18
11/15
07:39
11/15/18
07:39
Earnings
J.C. Penney withdraws FY18 earnings guidance »

Given the company has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

KBH

KB Home

$20.80

-0.135 (-0.64%)

07:39
11/15/18
11/15
07:39
11/15/18
07:39
Recommendations
KB Home analyst commentary  »

KB Home price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WYNN

Wynn Resorts

$103.24

1.19 (1.17%)

07:37
11/15/18
11/15
07:37
11/15/18
07:37
Initiation
Wynn Resorts initiated  »

Wynn Resorts initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

DDS

Dillard's

$73.63

-2.74 (-3.59%)

07:37
11/15/18
11/15
07:37
11/15/18
07:37
Hot Stocks
Dillard's reports Q3 comparable store sales up 3% »

Total merchandise sales…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JCP

J.C. Penney

$1.23

-0.05 (-3.91%)

07:36
11/15/18
11/15
07:36
11/15/18
07:36
Hot Stocks
J.C. Penney CEO Jill Soltau says path to profitable growth is clear »

Jill Soltau, CEO said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

DDS

Dillard's

$73.63

-2.74 (-3.59%)

07:36
11/15/18
11/15
07:36
11/15/18
07:36
Earnings
Dillard's reports Q3 EPS 27c, consensus 56c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COG

Cabot Oil & Gas

$25.83

-0.67 (-2.53%)

, PAGS

PagSeguro Digital

$23.19

0.565 (2.50%)

07:36
11/15/18
11/15
07:36
11/15/18
07:36
Options
Unusual call flow in option market yesterday »

Notable call activity was…

COG

Cabot Oil & Gas

$25.83

-0.67 (-2.53%)

PAGS

PagSeguro Digital

$23.19

0.565 (2.50%)

MOS

Mosaic

$35.72

-0.41 (-1.13%)

CRC

California Resources

$24.06

0.3 (1.26%)

CVE

Cenovus Energy

$8.14

-0.205 (-2.46%)

ON

ON Semiconductor

$17.47

0.12 (0.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 26

    Nov

  • 08

    May

JCP

J.C. Penney

$1.23

-0.05 (-3.91%)

07:34
11/15/18
11/15
07:34
11/15/18
07:34
Hot Stocks
Breaking Hot Stocks news story on J.C. Penney »

J.C. Penney reports Q3…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

CAT

Caterpillar

$125.04

-1 (-0.79%)

07:33
11/15/18
11/15
07:33
11/15/18
07:33
Recommendations
Caterpillar analyst commentary  »

Caterpillar public sector…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PAR

PAR Technology

$16.11

-0.51 (-3.07%)

07:33
11/15/18
11/15
07:33
11/15/18
07:33
Hot Stocks
PAR Technology subsidiary awarded $7.3M U.S. Navy contract at Aguada, PR »

PAR Technology announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OVID

Ovid Therapeutics

$4.75

-0.42 (-8.12%)

07:33
11/15/18
11/15
07:33
11/15/18
07:33
Initiation
Ovid Therapeutics initiated  »

Ovid Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

SPH

Suburban Propane

$22.68

0.12 (0.53%)

07:33
11/15/18
11/15
07:33
11/15/18
07:33
Earnings
Suburban Propane reports Q4 EPS (83c) vs. (83c) last year »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

OTIC

Otonomy

$2.34

-0.07 (-2.90%)

07:33
11/15/18
11/15
07:33
11/15/18
07:33
Initiation
Otonomy initiated  »

Otonomy initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

07:32
11/15/18
11/15
07:32
11/15/18
07:32
General news
U.S. stocks pointed to higher open despite UK's Brexit chaos »

U.S. futures are higher…

DNLI

Denali Therapeutics

$17.53

0.24 (1.39%)

07:32
11/15/18
11/15
07:32
11/15/18
07:32
Initiation
Denali Therapeutics initiated  »

Denali Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JCP

J.C. Penney

$1.23

-0.05 (-3.91%)

07:32
11/15/18
11/15
07:32
11/15/18
07:32
Earnings
J.C. Penney reports Q3 adj. EPS (52c), consensus (56c) »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

APTX

Aptinyx

$24.75

-0.76 (-2.98%)

07:32
11/15/18
11/15
07:32
11/15/18
07:32
Initiation
Aptinyx initiated  »

Aptinyx initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AN

AutoNation

$38.56

-0.73 (-1.86%)

07:31
11/15/18
11/15
07:31
11/15/18
07:31
Hot Stocks
AutoNation announces partnership with Fair »

AutoNation announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXSM

Axsome Therapeutics

$2.82

-0.07 (-2.42%)

07:31
11/15/18
11/15
07:31
11/15/18
07:31
Initiation
Axsome Therapeutics initiated  »

Axsome Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADS

Alliance Data

$199.76

-5.49 (-2.67%)

07:30
11/15/18
11/15
07:30
11/15/18
07:30
Hot Stocks
Alliance Data reports October net charge offs 5.7% vs. 5.9% last month »

Reports October…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

KBH

KB Home

$20.80

-0.135 (-0.64%)

07:30
11/15/18
11/15
07:30
11/15/18
07:30
Hot Stocks
KB Home lowers FY18 housing revenue view to $4.5B from $4.6B »

Sees Q4: housing revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYL

Mylan

$34.23

-1.53 (-4.28%)

07:28
11/15/18
11/15
07:28
11/15/18
07:28
Upgrade
Mylan rating change  »

Mylan upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JEC

Jacobs Engineering

$73.26

-1.38 (-1.85%)

07:28
11/15/18
11/15
07:28
11/15/18
07:28
Initiation
Jacobs Engineering initiated  »

Jacobs Engineering…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.